CBUAE XTransfer approval gives Dubai clinics 4 payment checks before switching

XTransfer's 3 September 2026 in-principle approval from the Central Bank of the United Arab Emirates (CBUAE) does one practical thing for Dubai clinics: it adds a potential regulated route for cross-border business payments, once final licence conditions are met.

For a clinic owner, CFO or COO, this is a payment procurement story rather than a healthcare licensing story. The Dubai Health Authority (DHA) remains the regulator for clinical facilities in Dubai. Department of Health Abu Dhabi (DOH) remains the healthcare regulator in Abu Dhabi and Al Ain. Ministry of Health and Prevention (MOHAP) remains relevant for the northern emirates. CBUAE regulates payment service providers, banks, exchange houses and insurers across the UAE.

What changes for a Dubai clinic

The change is narrow. A clinic that pays overseas laboratories, imports consumables, settles marketing invoices, or receives payments from medical tourism partners may soon have another CBUAE-supervised provider to compare with banks, exchange houses and payment platforms. XTransfer said the licence, after pre-issuance conditions, would allow it to serve mainland UAE clients and expand regulated B2B payment services. XTransfer's announcement did not give a final approval date.

The rule behind the approval is CBUAE's Retail Payment Services and Card Schemes Regulation. The framework covers nine retail payment service categories, including payment account issuance, merchant acquiring, payment aggregation, domestic fund transfer, cross-border fund transfer, payment initiation and payment account information services. The relevant question for a healthcare operator is the exact activity licensed, not the brand name on the sales deck.

• Ask for the final CBUAE licence number, not the in-principle approval notice.
• Check whether cross-border fund transfer, merchant acquiring or payment aggregation is actually included.
• Request the UAE contracting entity name and bank safeguarding arrangements.
• Map settlement timing against supplier due dates and patient refund policies.

What does not change

This approval does not change DHA, DOH or MOHAP obligations for clinical practice, facility licensing, medical advertising, patient records, insurance claims or consent. It also does not alter insurer contracts with Daman, Thiqa or Sukoon where those contracts apply. A payment vendor can move money. It cannot make a non-covered treatment reimbursable or shorten insurer pre-approval timelines.

For CFOs, the immediate work is a cost comparison. UAE merchant acquiring and payment gateway pricing is usually quoted as a percentage of transaction value, a fixed AED fee, monthly platform charges, FX spread, chargeback fees and payout timing. If a vendor will not give all five items in writing, the clinic cannot compare it with bank acquiring or existing payment links. For overseas payments, ask for the live FX spread against the clinic's bank quote on the same day, because headline transfer fees can be lower than the embedded currency cost.

There is also a patient-trust issue. Clinics using payment links for deposits, packages or medical tourism should make the contracting entity visible on invoices and receipts. If the provider changes, update refund wording before launch. That is operationally simple, but it matters when a patient disputes a deposit or a supplier says funds arrived short.

How to act before final approval

XTransfer said it was founded in 2017 and reported more than $60 billion in total payment volume in 2025, based on CIC research cited by the company. Those numbers indicate scale, but they do not replace UAE licence verification. The article in The Manila Times reported the same in-principle approval on 3 September 2026.

"Upon completing the pre-issuance conditions, the licence will enable XTransfer to serve mainland UAE clients." Bill Deng, founder and CEO, XTransfer.

The safest operating position is to treat XTransfer as a watchlist vendor until final CBUAE authorisation is public. Dubai clinic CFOs should review payment vendors at the next contract renewal, usually 30 to 90 days before expiry. COOs should involve finance, front desk and billing teams before replacing payment links, because patient-facing payment changes create reconciliation work on day one.

For clinics planning expansion, the broader signal is that CBUAE continues to open regulated payment lanes for non-bank providers. That may lower friction for cross-border suppliers and medical tourism partners, but only if the provider has the correct UAE licence scope. Use the UAE Open Healthcare Directory to check licensed clinic providers, then match each provider's payment process to its DHA, DOH or MOHAP operating footprint.